Overall rating: Hold. DCR’s short-term evidence is bearish: the price is down 2.41% over 24 hours and 6.22% over seven days, sits below all five listed hourly moving averages, and is trading in the lower part of its daily range. Countering that weakness, the 30-day change remains positive at 3.54%, while the one-hour RSI of 30 signals a potentially stretched short-term decline rather than confirming that selling pressure must continue.

At $17.23, DCR is below the 8-hourly SMA at $17.41 by 1.01%, and below the 13-, 21-, and 55-period averages by 1.20%, 1.29%, and 1.71%, respectively. It is also 4.19% below the 144-period SMA at $17.98, so the moving-average picture is consistently unfavorable and suggests weakness across the supplied hourly time frames.

The current price is $0.16 above the 24-hour low of $17.07 and $0.45 below the high of $17.68. That places it roughly 26% of the way up the $0.61 daily range, consistent with the negative daily change and indicating that the price is closer to the low than the high.

Momentum readings are mixed across horizons. The seven-day and 14-day changes are negative, at -6.22% and -2.53%, while the 30-day change is +3.54%; this points to recent deterioration within a still-positive monthly period, rather than uniform weakness across all measured periods.

The one-hour RSI at 30 is near the commonly used oversold threshold and could indicate that the immediate decline is extended. However, the seven-day RSI is 45, which is less extreme, and the price remains below every listed hourly average; together, these readings do not yet provide a strong reversal signal.

Reported 24-hour volume is 1,206,767, and volume relative to market capitalization is 0.40%. These figures provide activity context, but without a comparison period or additional volume data they do not establish whether participation is rising, falling, or confirming the price move.

DCR’s current price is about 93% below its all-time high of $247.35, recorded on April 16, 2021. That historical gap underscores the distance from the peak but does not by itself provide a near-term directional signal.

Hold best reflects the balance of evidence: negative daily and weekly performance, a low position in the daily range, and price below all listed moving averages argue against a Buy. The oversold-near one-hour RSI and positive 30-day change temper the case for a Sell, but neither outweighs the broader short-term weakness enough to support a bullish rating.